Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.34
0.032.29%
Last update: Oct 19, 12:55 PM
$1.40
0.08576.54%
ProQR Therapeutics NV (PRQR) Stock Price, Quote, News & History
PRQRNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ProQR Therapeutics (NASDAQ:PRQR) through any online brokerage.
Other companies in ProQR Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
ProQR Therapeutics has a consensus price target of $8.00.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $1.34 last updated October 19, 2026 at 12:55 PM EDT.
There are no upcoming dividends for ProQR Therapeutics.
ProQR Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for ProQR Therapeutics.
ProQR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
